ACI 2019

A consultant cadiologist at John Radcliffe Hospital, Oxford University, Oxford, UK. Features in 13 videos on Wondr Medical. Adrian Banning generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Multi Vessel Disease.

Andreas Baumbach is Chair of Device Innovation and Consultant Interventional Cardiologist at the Barts Heart Centre and Queen Mary University of London. He is active in coronary and structural intervention, and has published extensively in the field of interventional research covering preclinical, first in man, pivotal and post market studies. He has an interest in device innovation and regulatory pathways. Professor Baumbach has a strong commitment to training and education. He is on the board of directors of the largest interventional congress EuroPCR and PCR London Valves. He is the Immediate Past President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

A consultant cardiologist at Mater Private Hospital, Dublin, Ireland. Features in 20 videos on Wondr Medical. Colm Hanratty generally speaks on Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Chronic Total Occlusion (CTO), Calcium Scoring, and Stable Coronary Artery Disease (CAD).

David Hildick-Smith is an interventional Cardiologist of national and international renown. He undertakes procedures such as angioplasty, patent foramen ovale closure, atrial septal defect closure, left atrial appendage occlusion, transcatheter valve implantation and transcatheter mitral valve interventions. He does echocardiography onsite for relevant patients. He undertakes over 300 interventions per year at the Sussex Cardiac Centre and is Structural Heart lead for the British Cardiovascular Interventions Society.

Dr Peter O’Kane graduated from Charing Cross & Westminster Medical School in 1995 with First Class Honours Bachelor of Science BSc degree in Physiology, Medical Degree and numerous prizes including the Llewelyn Prize for the second-best distinction in medical finals. After attaining membership of the Royal College of Physicians he was subsequently awarded a Doctorate of Medicine by the University of London for a thesis on the role of nitric oxide in coronary heart disease. Dr O’Kane was appointed as Consultant Interventional Cardiologist at the Royal Bournemouth Hospital in July 2007. He has performed over 7000 PCI procedures as a Consultant. He routinely treats extensively calcified lesions, bifurcations including left main stem disease & chronic total occlusions. He is committed to teaching & education with local fellowship training program through to national & international proctorship of techniques & multiple adjunctive devices. He has trained Consultant colleagues from the UK, Europe, Asia & USA through local workshops and courses. He is regularly invited as faculty to National & International meetings as a presenter & live case operator. He has published over 70 manuscripts and authored 10 book chapters. He is a local principal Investigator for over 30 National & International multi-centre clinical trials & is dedicated to patient recruitment with over 900 patients recruited to trials he has managed. He has led numerous quality improvement programs, is PCI Lead, Cardiology Governance and Mortality Lead & has achieved National Bronze Clinical Excellence Award level 9. He was a nationally elected member to British Cardiovascular Intervention Society (BCIS) Council (2020-2023) and from March 2023 is a member of BCIS Research Working Group.

Professor Rajesh Kharbanda is a Consultant Cardiologist Oxford University Hospitals, UK with over 20 years of experience in treating patients with a wide range of heart conditions including angina, valve disease, heart failure and irregular heart rhythm. He has special expertise in the treatment of coronary artery disease by coronary angioplasty and stenting including complex angioplasty techniques as well as Structural Heart interventions. He has published and co-authored over 240 scientific papers in peer-reviewed journals and actively involved in international trials evaluating various coronary and transcatheter valve technologies.